Replies to post #389367 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

However, it should shut down the speculations raised by some that the control arm of the trial has survival durations close to those of the treatment arm. The patients with the "real" GBM don't derive much survival benefit from the current SOC.